α-alanine was adopted as a new additive to elucidate the seeded precipitation mechanism of sodium aluminate solution. α-alanine has the inhibitory effect at the initial period of reaction, but the favorable effect i...α-alanine was adopted as a new additive to elucidate the seeded precipitation mechanism of sodium aluminate solution. α-alanine has the inhibitory effect at the initial period of reaction, but the favorable effect in subsequent reaction. The combined effect of amino and carboxyl group in α-alanine was confirmed by investigating the effect of propionic acid, ethamine and the mixture of propionic acid and ethamine (mole ratio 1-1) on the precipitation of sodium aluminate solution, respectively. The inhibitory effect derives from the adsorption of amino or carboxyl group in α-alanine on the active surface sites of gibbsite, which was confirmed by the alleviating inhibitory effects of propionic acid, ethamine and α-alanine due to the double crystal seed mass. The semi-quantitative IR spectrum analysis of the relative concentrations of Al2O(OH)62- with the band at about 550 cm-1 and polynuclear aluminate ion with the bands at about 880 cm-1 and 635 cm-1, indicates that the dynamic balance among some aluminate species present in sodium aluminate solution is broken due to the addition of α-alanine, thus resulting in the change of the seeded precipitation ratio of sodium aluminate solution.展开更多
Water-uptakes of pure sodium carbonate(Na2CO3),pureβ-alanine and internally mixedβ-alanine/Na2CO3 aerosol particles with different mole ratios are first monitored using attenuated total reflectance Fourier transform...Water-uptakes of pure sodium carbonate(Na2CO3),pureβ-alanine and internally mixedβ-alanine/Na2CO3 aerosol particles with different mole ratios are first monitored using attenuated total reflectance Fourier transform infrared spectroscopy(ATR-FTIR)technique.For pure Na2CO3 aerosol particles,combining the absorptions at 877 and 1422 cm-1 with abrupt water loss shows the efflorescence relative humidity(ERH)of 62.9%–51.9%.Upon humidifying,solid Na2CO3 firstly absorbs water to from Na2CO3·H2O crystal at 72.0%RH and then deliquesces at 84.5%RH(DRH).As for pureβ-alanine particles,the crystallization takes place in the range of 42.4%–33.2%RH and becomes droplets at^88.2%RH.Whenβ-alanine is mixed with Na2CO3 at various mole ratios,it shows no efflorescence of Na2CO3 whenβ-alanine to Na2CO3 mole ratio(OIR)is 2:1.For 1:1 and 1:2β-alanine/Na2CO3 aerosols,the ERHs of Na2CO3 are 51.8%–42.3%and 57.1%–42.3%,respectively.Whileβ-alanine crystal appears from 62.7%RH for 2:1 and 59.4%RH for both 1:1 and 1:2 particles and lasts to driest state.On hydration,the DRH is 44.7%–75.2%for Na2CO3 with the OIR of 1:1 and 44.7%–69.0%for 1:2 mixture,and those of β-alanine are 74.8% for 2:1 mixture and 68.9%for two others.After the first dehumidification–humidification,all the water contents decrease despite of constituent fraction.And at^92%RH,the remaining water contents are 92%,89%and 82%at^92%RH,corresponding to OIR of 2:1,1:1 and 1:2 mixed system,respectively.展开更多
BACKGROUND Non-alcoholic fatty liver disease(NAFLD)is a common comorbidity with type 2 diabetes.The existing therapeutic options for NAFLD are not adequate.Hypocaloric diet and exercise is the cornerstone of therapy i...BACKGROUND Non-alcoholic fatty liver disease(NAFLD)is a common comorbidity with type 2 diabetes.The existing therapeutic options for NAFLD are not adequate.Hypocaloric diet and exercise is the cornerstone of therapy in NAFLD.Pioglitazone is the only drug recommended in diabetes patients with biopsy proven non-alcoholic steatohepatitis.The frequent coexistence of NAFLD and type 2 diabetes with their combined adverse health consequences and inadequate therapeutic options makes it necessary to search for newer alternatives.AIM To assess the effect of sodium glucose cotransporter-2(SGLT-2)inhibitors on liver enzymes in type 2 diabetes patients with NAFLD.METHODS We searched PubMed/MEDLINE,Cochrane library,Google scholar,and Clinicaltrials.gov for the relevant articles to be included in this systematic review.Human studies done in type 2 diabetes patients with NAFLD treated with SGLT-2 inhibitors for at least 12 wk were included.Data from eight studies(four randomised controlled trials and four observational studies)were extracted and a narrative synthesis was done.A total of 214 patients were treated with SGLT-2 inhibitors in these studies(94 in randomised controlled trials and 120 in observational studies).RESULTS The primary outcome measure was change in serum alanine aminotransferase level.Out of eight studies,seven studies showed a significant decrease in serum alanine aminotransferase level.Most of the studies revealed reduction in serum level of other liver enzymes like aspartate aminotransferase and gamma glutamyl transferase.Five studies that reported a change in hepatic fat exhibited a significant reduction in hepatic fat content in those treated with SGLT-2 inhibitors.Likewise,among the three studies that evaluated a change in indices of hepatic fibrosis,two studies revealed a significant improvement in liver fibrosis.Moreover,there was an improvement in obesity,insulin resistance,glycaemia,and lipid parameters in those subjects taking SGLT-2 inhibitors.The studies disclosed that about 17%(30/176)of the subjects taking SGLT-2 inhibitors developed adverse events and more than 40%(10/23)of them had genitourinary tract infections.CONCLUSION Based on low to moderate quality of evidence,SGLT-2 inhibitors improve the serum level of liver enzymes,decrease liver fat,and fibrosis with additional beneficial effects on various metabolic parameters in type 2 diabetes patients with NAFLD.展开更多
New glucose-lowering agents reduce liver enzyme levels and blood pressure(BP).Whether this finding can be extended to non-alcoholic fatty liver disease(NAFLD)patients,in whom a bidirectional association of NAFLD measu...New glucose-lowering agents reduce liver enzyme levels and blood pressure(BP).Whether this finding can be extended to non-alcoholic fatty liver disease(NAFLD)patients,in whom a bidirectional association of NAFLD measures and BP has been also demonstrated,remains by and large unknown.展开更多
基金Project(20476107) supported by the National Natural Science Foundation of ChinaProject(2005CB623702) supported by the National Basic Research Program of China
文摘α-alanine was adopted as a new additive to elucidate the seeded precipitation mechanism of sodium aluminate solution. α-alanine has the inhibitory effect at the initial period of reaction, but the favorable effect in subsequent reaction. The combined effect of amino and carboxyl group in α-alanine was confirmed by investigating the effect of propionic acid, ethamine and the mixture of propionic acid and ethamine (mole ratio 1-1) on the precipitation of sodium aluminate solution, respectively. The inhibitory effect derives from the adsorption of amino or carboxyl group in α-alanine on the active surface sites of gibbsite, which was confirmed by the alleviating inhibitory effects of propionic acid, ethamine and α-alanine due to the double crystal seed mass. The semi-quantitative IR spectrum analysis of the relative concentrations of Al2O(OH)62- with the band at about 550 cm-1 and polynuclear aluminate ion with the bands at about 880 cm-1 and 635 cm-1, indicates that the dynamic balance among some aluminate species present in sodium aluminate solution is broken due to the addition of α-alanine, thus resulting in the change of the seeded precipitation ratio of sodium aluminate solution.
基金supported by the National Natural Science Foundation of China(Nos.91644101,91544223 and 21373026)
文摘Water-uptakes of pure sodium carbonate(Na2CO3),pureβ-alanine and internally mixedβ-alanine/Na2CO3 aerosol particles with different mole ratios are first monitored using attenuated total reflectance Fourier transform infrared spectroscopy(ATR-FTIR)technique.For pure Na2CO3 aerosol particles,combining the absorptions at 877 and 1422 cm-1 with abrupt water loss shows the efflorescence relative humidity(ERH)of 62.9%–51.9%.Upon humidifying,solid Na2CO3 firstly absorbs water to from Na2CO3·H2O crystal at 72.0%RH and then deliquesces at 84.5%RH(DRH).As for pureβ-alanine particles,the crystallization takes place in the range of 42.4%–33.2%RH and becomes droplets at^88.2%RH.Whenβ-alanine is mixed with Na2CO3 at various mole ratios,it shows no efflorescence of Na2CO3 whenβ-alanine to Na2CO3 mole ratio(OIR)is 2:1.For 1:1 and 1:2β-alanine/Na2CO3 aerosols,the ERHs of Na2CO3 are 51.8%–42.3%and 57.1%–42.3%,respectively.Whileβ-alanine crystal appears from 62.7%RH for 2:1 and 59.4%RH for both 1:1 and 1:2 particles and lasts to driest state.On hydration,the DRH is 44.7%–75.2%for Na2CO3 with the OIR of 1:1 and 44.7%–69.0%for 1:2 mixture,and those of β-alanine are 74.8% for 2:1 mixture and 68.9%for two others.After the first dehumidification–humidification,all the water contents decrease despite of constituent fraction.And at^92%RH,the remaining water contents are 92%,89%and 82%at^92%RH,corresponding to OIR of 2:1,1:1 and 1:2 mixed system,respectively.
文摘BACKGROUND Non-alcoholic fatty liver disease(NAFLD)is a common comorbidity with type 2 diabetes.The existing therapeutic options for NAFLD are not adequate.Hypocaloric diet and exercise is the cornerstone of therapy in NAFLD.Pioglitazone is the only drug recommended in diabetes patients with biopsy proven non-alcoholic steatohepatitis.The frequent coexistence of NAFLD and type 2 diabetes with their combined adverse health consequences and inadequate therapeutic options makes it necessary to search for newer alternatives.AIM To assess the effect of sodium glucose cotransporter-2(SGLT-2)inhibitors on liver enzymes in type 2 diabetes patients with NAFLD.METHODS We searched PubMed/MEDLINE,Cochrane library,Google scholar,and Clinicaltrials.gov for the relevant articles to be included in this systematic review.Human studies done in type 2 diabetes patients with NAFLD treated with SGLT-2 inhibitors for at least 12 wk were included.Data from eight studies(four randomised controlled trials and four observational studies)were extracted and a narrative synthesis was done.A total of 214 patients were treated with SGLT-2 inhibitors in these studies(94 in randomised controlled trials and 120 in observational studies).RESULTS The primary outcome measure was change in serum alanine aminotransferase level.Out of eight studies,seven studies showed a significant decrease in serum alanine aminotransferase level.Most of the studies revealed reduction in serum level of other liver enzymes like aspartate aminotransferase and gamma glutamyl transferase.Five studies that reported a change in hepatic fat exhibited a significant reduction in hepatic fat content in those treated with SGLT-2 inhibitors.Likewise,among the three studies that evaluated a change in indices of hepatic fibrosis,two studies revealed a significant improvement in liver fibrosis.Moreover,there was an improvement in obesity,insulin resistance,glycaemia,and lipid parameters in those subjects taking SGLT-2 inhibitors.The studies disclosed that about 17%(30/176)of the subjects taking SGLT-2 inhibitors developed adverse events and more than 40%(10/23)of them had genitourinary tract infections.CONCLUSION Based on low to moderate quality of evidence,SGLT-2 inhibitors improve the serum level of liver enzymes,decrease liver fat,and fibrosis with additional beneficial effects on various metabolic parameters in type 2 diabetes patients with NAFLD.
文摘New glucose-lowering agents reduce liver enzyme levels and blood pressure(BP).Whether this finding can be extended to non-alcoholic fatty liver disease(NAFLD)patients,in whom a bidirectional association of NAFLD measures and BP has been also demonstrated,remains by and large unknown.